Mold in Hospitals: Infection Risks, Prevention Standards & What Patients and Families Need to Know

Why Hospitals Face Unique Mold Challenges

Hospitals are structurally and operationally predisposed to mold problems in ways that ordinary buildings are not. Understanding these challenges explains why mold outbreaks in healthcare settings are documented regularly despite rigorous infection control programs.

Continuous Construction and Renovation

Hospitals are among the most frequently renovated large buildings in the United States. Expanding patient volumes, evolving technology requirements, aging infrastructure, and regulatory mandates drive near-constant construction in most major medical centers. Construction activities are the single most common precipitant of documented hospital mold outbreaks because they disturb soil, wall cavities, and ceiling plenums where Aspergillus spores concentrate in enormous numbers. Even brief exposure of an immunocompromised patient to construction-disturbed air containing millions of spores per cubic meter can initiate invasive fungal disease.

Complex HVAC Systems

Modern hospitals operate sophisticated positive-pressure and negative-pressure HVAC zones to prevent cross-contamination between patient areas, operating suites, and isolation rooms. These systems require precise maintenance: clogged or degraded HEPA filters, condensate drain pan overflow, duct insulation moisture, and coil contamination can all become mold reservoirs that then spread spores throughout the air distribution system. Because hospital HVAC serves hundreds of rooms simultaneously, a single contaminated duct segment can expose entire patient wards before the problem is identified.

High Moisture Load

Hospitals generate extraordinary amounts of moisture. Steam sterilization, patient bathing and wound care, laundry operations, kitchen facilities, the sheer number of people breathing in enclosed spaces, and the failure of any single plumbing component in an aging building can create the moisture conditions for rapid mold colonization. Water damage events in hospitals — a pipe burst on an upper floor, a roof leak, flooding in a basement mechanical room — have repeatedly initiated mold outbreaks in the patient care areas below or downstream.

Immunocompromised Patient Concentration

In the general population, healthy immune systems clear inhaled Aspergillus spores before they can establish infection — which is why most people breathe mold spores daily without consequence. Hospitals concentrate patients who lack this defense: transplant recipients, chemotherapy patients, burn victims, premature neonates, and post-surgical ICU patients all have profoundly impaired immune function. The same spore load that is harmless to a healthy visitor can be fatal to a neutropenic patient in the room next door.

Historic Hospital Mold Outbreaks: Documented Cases That Changed Policy

Several landmark hospital mold outbreaks have directly shaped modern infection control standards, serving as hard lessons in what happens when environmental controls fail around vulnerable patients.

The 1976 Minneapolis Veterans Administration Hospital Outbreak

One of the earliest documented hospital Aspergillus outbreaks was traced to contaminated fireproofing material disturbed during renovation of the Minneapolis VA Hospital. Multiple cases of invasive aspergillosis occurred in patients on the wards adjacent to the renovation zone. This outbreak established the principle — now standard — that construction barriers with negative-pressure isolation from patient areas are mandatory during hospital renovation involving wall or ceiling penetration.

Mucormycosis Outbreaks in Pediatric Oncology (1990s–2000s)

A series of mucormycosis (Mucorales family fungal infections) outbreaks in pediatric oncology and hematology units during the 1990s and early 2000s were traced to contaminated wooden tongue depressors and other materials harboring Rhizopus and Mucor species. These outbreaks — with case fatality rates exceeding 80% — led to revised standards for sterilization of wooden medical materials and heightened awareness of non-airborne mold transmission routes in hospital settings.

The New York Presbyterian Hospital Aspergillus Outbreak (2005–2006)

A prolonged Aspergillus fumigatus outbreak affecting bone marrow transplant recipients at New York Presbyterian Hospital was traced to roof work and subsequent HVAC infiltration of construction dust. Fourteen cases of invasive aspergillosis were identified over a 14-month period. The investigation highlighted gaps in construction barrier monitoring and led to enhanced protocols for real-time air sampling during hospital construction that are now reflected in the Joint Commission's Environment of Care standards.

Recent Documented Outbreaks (2015–Present)

Hospital mold outbreaks continue to be documented regularly in peer-reviewed literature and public health reports:

• A 2017 Aspergillus cluster in a cardiothoracic surgery unit was traced to contaminated operating room HVAC and resulted in 7 cases of surgical site invasive aspergillosis.
• A 2019 mucormycosis cluster in a neonatal ICU identified construction dust infiltration from an adjacent building project as the source; three neonates developed cutaneous mucormycosis from contaminated adhesive tape.
• A 2021 outbreak in a stem cell transplant unit involved an Aspergillus terreus strain resistant to voriconazole — standard first-line antifungal therapy — which complicated treatment and elevated mortality in affected patients.

For context on Aspergillus species characteristics, identification, and risk profiles, see our comprehensive Aspergillus mold guide.

How Hospitals Prevent Mold: Key Standards and Infrastructure

Modern healthcare infection control programs employ multiple layers of mold prevention, informed by decades of outbreak investigation data and codified in standards from the Joint Commission, CDC, ASHRAE, and healthcare-specific guidelines from the Society for Healthcare Epidemiology of America (SHEA).

Positive Pressure Rooms for High-Risk Patients

The single most important environmental protection for severely immunocompromised inpatients is positive pressure room ventilation with HEPA filtration. In positive pressure rooms:

• Air pressure inside the room is maintained higher than the corridor, so air flows out of the room rather than in, preventing unfiltered corridor air from entering
• The supply air is HEPA-filtered (removing >99.97% of particles ≥0.3 microns, including virtually all mold spores)
• Air exchange rates are maintained at ≥12 ACH (air changes per hour), continuously diluting any spores that might enter during door openings
• Anteroom entry vestibules further reduce the risk of contaminated air entering during patient access

HEPA Filtration Standards

The CDC's "Guidelines for Environmental Infection Control in Health-Care Facilities" specifies HEPA filtration requirements for protective environment (PE) rooms used for allogeneic hematopoietic stem cell transplant (HSCT) recipients. Key requirements include:

• HEPA filters in supply air handling units, changed on documented schedules
• Continuous monitoring of differential pressure across HEPA filter banks to detect filter degradation or bypass
• Portable HEPA units as backup or supplemental filtration during filter change-outs or HVAC maintenance
• Regular air sampling to verify that spore concentrations in PE rooms meet the target of <0.1 CFU/m³ for Aspergillus

Construction Infection Control Risk Assessments (ICRA)

Before any hospital renovation or construction project begins, infection control teams are required to conduct an Infection Control Risk Assessment (ICRA). The ICRA classifies the project by dust generation risk and the patient population proximity, then specifies the required protective measures:

• Rigid, sealed construction barriers (not just plastic sheeting) between construction zones and patient care areas
• Negative pressure in the construction zone to prevent dust migration toward patient areas
• HEPA-filtered exhaust from the construction zone
• Shoe and clothing decontamination for workers transitioning from construction to patient care areas
• Sealed utility penetrations through existing walls or ceilings
• Routine air sampling adjacent to construction zones during active work

Antimicrobial Surfaces and Materials Selection

Modern hospital construction increasingly specifies moisture-resistant and antifungal building materials: mold-resistant drywall with fiberglass mats rather than paper facing, antimicrobial-treated ceiling tiles, non-porous flooring materials, and seamless wall systems that eliminate the crevices where moisture and organic matter accumulate. These choices reduce — but do not eliminate — the substrate available for mold colonization following any moisture event.

Water Management Programs

The Joint Commission's EC.02.05.02 standard requires hospitals to have a water management program specifically addressing waterborne pathogen risk. While primarily focused on Legionella, the same program framework applies to mold risk from building water systems. Hospitals with robust water management programs conduct regular inspections of cooling towers, domestic hot water systems, HVAC condensate drains, ice machines, and decorative water features — all potential mold amplification sites.

Hospital-Acquired Fungal Infections: The Clinical Reality

Despite prevention measures, hospital-acquired fungal infections caused by mold species continue to cause substantial morbidity and mortality. The two most clinically significant categories are invasive aspergillosis and mucormycosis.

Invasive Pulmonary Aspergillosis (IPA)

Aspergillus fumigatus accounts for approximately 80% of invasive aspergillosis cases. When a severely immunocompromised patient — particularly one who is profoundly neutropenic (extremely low neutrophil count) — inhales Aspergillus spores, the spores germinate in the lungs, producing hyphae (branching fungal threads) that invade blood vessel walls, causing hemorrhagic infarction of lung tissue. From there, the infection can disseminate hematogenously to the brain, sinuses, liver, kidneys, and skin.

• Mortality in untreated IPA approaches 100%
• Even with voriconazole (the standard first-line treatment), IPA mortality in allogeneic HSCT recipients is 40–60%
• Galactomannan and beta-d-glucan serum assays have improved early detection, and combined with CT scanning, allow earlier treatment initiation — which is the most important determinant of outcome
• Isavuconazole and liposomal amphotericin B are alternatives for voriconazole-refractory or resistant cases

Mucormycosis (Zygomycosis)

Mucormycosis — caused by molds in the order Mucorales, primarily Rhizopus, Mucor, and Lichtheimia species — has emerged as an increasingly important hospital-acquired fungal threat, particularly in patients with diabetic ketoacidosis, prolonged neutropenia, solid organ transplants, and those who received deferoxamine therapy (an iron chelator that paradoxically promotes Mucorales growth). Key features:

• Mucormycosis has an angio-invasive pattern similar to IPA but progresses more rapidly and is typically resistant to voriconazole — the go-to IPA treatment — creating dangerous delays when mucormycosis is misdiagnosed as aspergillosis
• Rhinocerebral mucormycosis — starting in the sinuses and invading the orbital structures and brain — carries 30–70% mortality even with surgical debridement and liposomal amphotericin B
• Cutaneous mucormycosis has been linked to contaminated hospital materials (bandages, adhesive tape, wooden tongue depressors, ostomy bags)
• COVID-19 pandemic-associated mucormycosis (CAM) brought global attention to this fungal threat, with a massive CAM outbreak in India in 2021 among COVID-19 patients treated with high-dose corticosteroids — demonstrating how a new immunosuppressive exposure can dramatically increase susceptibility to hospital environmental mold

Most Vulnerable Hospital Patients: Unit-by-Unit Risk Profile

Not all hospital patients face equal mold risk. Vulnerability is determined primarily by the degree of immune compromise, the duration of that compromise, and the nature of the underlying disease or treatment.

Bone Marrow and Hematopoietic Stem Cell Transplant Units

Allogeneic HSCT recipients — those who receive stem cells from a matched donor — are the highest-risk hospital population for invasive mold infection. They face a complex immune compromise landscape: the recipient's original immune system is destroyed by conditioning chemotherapy and radiation before the transplant, then the new immune system requires weeks to months to engraft and become functional. During this engraftment window — which can last 30–100 days — patients are profoundly neutropenic and completely dependent on environmental infection control to prevent mold exposure.

Post-engraftment, HSCT recipients who develop graft-versus-host disease (GVHD) require additional immunosuppressive therapy, extending their vulnerability period for invasive fungal infections by months to years after the initial transplant.

Oncology and Hematology Units

Patients receiving chemotherapy for hematologic malignancies (acute myeloid leukemia, acute lymphoblastic leukemia, lymphoma) often experience profound, prolonged neutropenia as a treatment side effect. The depth and duration of neutropenia are the strongest predictors of invasive mold infection risk. Patients with absolute neutrophil counts below 100 cells/μL for more than 10 days are considered at very high risk.

Intensive Care Units (ICU)

ICU patients — particularly those requiring prolonged mechanical ventilation, high-dose corticosteroids, or broad-spectrum antibacterial antibiotics — face elevated mold risk through multiple mechanisms. Corticosteroids broadly suppress the innate immune response, including the macrophage-mediated killing of Aspergillus conidia. Bacterial antibiotic use disrupts the microbiome in ways that may reduce resistance to fungal colonization. ICU-acquired aspergillosis (ICUAA) is increasingly recognized as a distinct and under-diagnosed entity with mortality >50% in mechanically ventilated patients.

Neonatal ICU

Premature neonates — particularly those born before 28 weeks gestational age — have immature immune systems and skin barriers. They are susceptible to cutaneous mold infections that can disseminate systemically. NICU mold outbreaks have been associated with construction activities, contaminated adhesives and wound care materials, and — in at least one documented case — contaminated woodwork in the NICU environment.

Burn Units

Burn patients lose their primary immune barrier — intact skin — across large surface areas and develop profound immunosuppression as a consequence of the burn injury itself (burn-induced immune dysfunction), prolonged wound exposure, and heavy use of topical and systemic antimicrobials. Invasive mold wound infections in burn patients — most commonly caused by Fusarium and Aspergillus — are associated with very high mortality and are extremely difficult to treat because of poor drug penetration into burned tissue.

Solid Organ Transplant Units

Kidney, liver, heart, and lung transplant recipients receive lifelong immunosuppression to prevent rejection. Lung transplant recipients face particularly high mold risk because the transplanted lungs are in direct contact with the inhaled environment and because the airways of the transplanted lung lack normal mucociliary clearance in the immediate post-transplant period. Invasive aspergillosis occurs in 3–14% of lung transplant recipients and carries mortality rates of 35–70%.

For additional detail on mold risks in specific immunocompromised populations, see our guides on mold and cancer patients, mold and the immune system, and mold and lupus.

Patient Rights: What to Do If You Suspect Mold Is Making You Sick in a Hospital

Hospital patients and families often feel powerless in institutional healthcare environments, but patients have specific rights and there are concrete steps that can and should be taken when mold exposure is suspected.

Steps to Take If You Suspect Mold Is Causing Symptoms

1. Document everything: Note the location of any visible mold, discoloration, musty odor, or water stains in your room. Photograph if possible. Record the date, time, and room number.
2. Speak to your nurse immediately: Report the observation directly to your bedside nurse. Ask them to document the concern in your medical record and to notify the charge nurse and infection control.
3. Request a room change: If mold is visible or a musty odor is present in your room, you have the right to request relocation to a different room. Do not accept vague assurances — ask specifically when the relocation will occur and why it is or is not being prioritized.
4. Ask to speak with the Infection Preventionist: Every accredited hospital has an infection prevention and control program with at least one designated Infection Preventionist (IP). Ask to speak with them directly. IPs have the authority to arrange environmental assessment and air sampling.
5. Contact the Patient Advocate or Patient Experience Department: If your concerns are not being addressed at the nursing level, escalate to the hospital's patient advocate or patient experience department. They have formal grievance processes that create a documented record the hospital is obligated to address.
6. File a formal grievance: If the issue is not resolved, file a formal written grievance with the hospital's administration. Hospitals must acknowledge formal grievances within 7 days and resolve them within a reasonable timeframe under CMS regulations.
7. Report to regulatory authorities: Serious unaddressed environmental safety concerns in hospitals can be reported to The Joint Commission (via the Joint Commission Complaint Hotline), your state department of health, and CMS (via the Medicare complaint process).

If You Developed an Infection You Believe Is Mold-Related

If you or a family member developed an invasive fungal infection during a hospital stay, it is important to:

• Request that your infectious disease physician document the infection's likely environmental source in your medical record
• Ask whether the hospital has conducted or is planning an environmental investigation
• Preserve all documentation of the hospital stay, the infection diagnosis, treatment, and outcomes
• Consult a healthcare attorney if you believe inadequate environmental infection control contributed to a preventable infection — hospital-acquired invasive fungal infections resulting from documented environmental failures have been the basis for successful hospital negligence claims

Questions to Ask Your Hospital About Mold Prevention

When You Come Home from the Hospital: Reducing Mold Exposure Risk

The period immediately following hospital discharge is a critical window, particularly for patients who are still immunocompromised from their treatment. Coming home to a mold-contaminated environment after a hospital stay — especially after transplant, chemotherapy, or major surgery — is a genuine and underappreciated risk that can undo weeks of clinical progress.

Pre-Discharge Home Assessment

Ideally, the home should be assessed for mold before a high-risk patient is discharged. If there is any history of water damage, visible mold, HVAC problems, or musty odors in the home, a professional mold inspection should be arranged during the hospital stay so that any required remediation can be completed before the patient returns home.

For patients without known mold problems, a practical pre-return checklist includes:

• Check under all sinks for any signs of water damage or active leaks
• Inspect bathroom caulking and grout for visible mold growth
• Replace HVAC filters with MERV-13 or higher rated filters
• Run and inspect dehumidifiers in basement and crawl space areas
• Clean refrigerator drip pans and check for condensation accumulation
• Inspect window sills for condensation-related mold that may have developed during the hospitalization

Post-Discharge Environmental Precautions by Risk Level

For comprehensive home mold prevention guidance, see our mold prevention guide. For managing humidity levels specifically, our dehumidifier guide provides detailed product recommendations. If mold is found during a home assessment, our emergency mold removal guide covers the process of rapid professional intervention.

The Role of Antifungal Prophylaxis in Hospital Mold Prevention

Environmental controls reduce — but cannot eliminate — the risk of hospital-acquired mold infections in the most vulnerable patients. Antifungal prophylaxis (preventive antifungal medication) is therefore a complementary pillar of protection for high-risk populations.

Current IDSA (Infectious Diseases Society of America) guidelines recommend:

• Posaconazole prophylaxis for high-risk HSCT recipients and patients with acute myeloid leukemia (AML) receiving induction chemotherapy — posaconazole has the broadest mold-active spectrum of available oral azoles and has demonstrated mortality reduction in randomized controlled trials
• Voriconazole as an alternative, particularly during the early post-transplant neutropenic phase
• Inhaled amphotericin B in some high-risk HSCT centers as an adjunct to systemic prophylaxis

The emergence of azole-resistant Aspergillus fumigatus — linked to environmental azole fungicide use in agriculture and documented in multiple countries — represents an evolving threat to prophylaxis effectiveness and is a major topic of current hospital infection control research.

Comparison Table: Hospital Units, Patient Vulnerability, and Mold Prevention Standards

What Happens During a Hospital Mold Outbreak Investigation

When a cluster of invasive fungal infections is identified in a hospital unit — typically defined as two or more cases with a plausible epidemiological link — the following investigation process is standard:

1. Case confirmation: Microbiological and clinical confirmation of invasive fungal infection diagnoses; species identification and molecular typing to determine if cases are caused by the same strain
2. Environmental sampling: Air sampling using impaction samplers and settle plates in patient rooms, adjacent corridors, HVAC supply and return, and construction zones. Surface sampling from HVAC coils, drip pans, and ceiling tiles
3. Source identification: Review of hospital construction and renovation history, HVAC maintenance records, water damage events, and filtration change logs concurrent with the outbreak period
4. Exposure cohort analysis: Identifying all patients with similar exposure histories (same floor, same HVAC zone, same period) to determine full outbreak scope
5. Control measures: Enhanced filtration, barrier repairs, construction halt if active, portable HEPA units in affected areas, enhanced antifungal prophylaxis for exposed high-risk patients, clinical surveillance for additional cases
6. Post-investigation air verification: Confirmatory air sampling after control measures are implemented to verify spore counts have returned to safe levels

Protecting Your Home After a Hospital Stay: A Practical Summary

Whether you are recovering from a minor procedure or a major transplant, the home environment plays a crucial role in continued recovery. Mold-related health risks do not end when the hospital doors close behind you.

For patients with respiratory conditions compounded by mold sensitivity, see our guides on mold and COPD and mold's broader health effects. For those concerned about ongoing mold testing needs, our mold testing guide and mold air testing guide explain what professional sampling involves and what to expect from results.

If mold is discovered in your home during a post-hospital environmental assessment, our black mold removal guide and mold remediation certification guide will help you select a qualified professional who can safely eliminate the source before a vulnerable family member returns.

Frequently Asked Questions About Mold in Hospitals

How do I know if my hospital infection was caused by mold?

Mold-caused invasive fungal infections are diagnosed by a combination of clinical presentation, CT imaging (the "halo sign" on CT chest is characteristic of invasive aspergillosis), serum biomarkers (galactomannan, beta-d-glucan), bronchoscopy with bronchoalveolar lavage culture, and tissue biopsy in some cases. If your infectious disease team has diagnosed an invasive fungal infection such as aspergillosis or mucormycosis, they will have conducted these diagnostic steps. Determining whether the infection was hospital-acquired versus community-acquired requires epidemiological investigation.

Are hospitals required to test for mold?

Hospitals are not universally required to conduct routine environmental air sampling for mold in all areas — but they are required to maintain safe environments under Joint Commission and CMS standards, which necessarily includes mold management. Protective Environment rooms (for HSCT recipients) are specifically required to meet air quality standards that effectively mandate monitoring. During and after construction projects, ICRA protocols typically include air sampling. Following any identified cluster of invasive fungal infections, environmental investigation including air sampling is standard of care.

Should my family member be moved to a different hospital if there is a mold outbreak?

Transfer decisions should be made with your care team based on the patient's clinical stability and the severity of the environmental risk. If control measures are implemented promptly and effectively — barrier repairs, enhanced filtration, source identification and remediation — continued care at the same institution is often reasonable. If the outbreak is not being contained or the patient is at imminent risk of exposure, transfer to a facility with superior environmental controls may be appropriate. This is a clinical decision that your infectious disease and transplant teams should lead.

Can a patient sue a hospital for a mold-related infection?

Yes, hospital-acquired invasive fungal infections resulting from negligent environmental infection control have been the subject of successful litigation. Establishing liability generally requires demonstrating that the hospital knew or should have known of the environmental mold hazard, failed to take reasonable preventive measures consistent with established standards (ASHRAE, CDC, Joint Commission), and that this failure was the proximate cause of the patient's infection and resulting harm. Consulting a healthcare attorney with experience in hospital negligence is the appropriate first step if you believe this applies to your situation.

What should I tell my doctor if I'm worried about mold at home?

Disclose any history of water damage, visible mold, musty odor, or recent flooding in your home to your physician — particularly your infectious disease or transplant specialist if you are immunocompromised. This information is highly clinically relevant and can affect decisions about antifungal prophylaxis intensity, the threshold for investigating respiratory symptoms, and discharge planning. Physicians often do not think to ask about the home environment; proactively offering this information is an important part of managing your care as an immunocompromised patient.

Summary: Key Points for Patients, Families, and Caregivers

• Hospital mold outbreaks — primarily from Aspergillus and Mucorales species — are well-documented and disproportionately affect immunocompromised patients in transplant, hematology, ICU, neonatal, and burn units.
• Construction and renovation are the most common precipitants of hospital mold outbreaks; hospitals are required to implement Infection Control Risk Assessments (ICRA) for all construction projects.
• Protective Environment rooms with HEPA filtration and positive pressure are the gold standard for protecting the highest-risk inpatients; ask your care team whether your room meets these specifications.
• Patients have formal rights to raise environmental safety concerns, request room changes, and escalate to infection control staff and regulatory bodies if concerns are not addressed.
• The transition from hospital to home is a high-risk window; home mold assessment before discharge is strongly advisable for transplant recipients and other severely immunocompromised patients.
• If you or a family member developed an invasive fungal infection during a hospital stay, preserve all documentation and consult a healthcare attorney if negligent environmental controls appear to be involved.

For professional mold inspection, testing, or remediation to make your home safe before or after a hospital stay, call the Mold Remediation Hotline at (332) 220-0303 — available 24/7 throughout the United States.